You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 196141 - 196150 of 202203 results
  1. Human Rabies Virus Vaccine Development

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Rabies is a major global health issue that kills approximately 40,000 to 70,000 people per year and over 10 million people who receive post-exposure prophylaxis (PEP) after exposure to potentially infected animals. Cost and compliance issues have greatly hampered the effectiveness of current vaccines. To confound this issue, current vaccines are not effective ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  2. Human Rabies Virus Vaccine Development

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Current human rabies virus (RV) vaccines are effective if administered in an appropriate and timely manner and therefore, RV infection is a vaccine-preventable disease. However, immunization protocols are complex, requiring multiple doses over a period of weeks and in some cases months. High costs and the lack of compliance associated with current vaccines, and ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  3. A novel vaccine: botulinum neurotoxin subunit on a viral carrier.

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): According to the NIAID fact sheet on Botulism, the extreme toxicity of botulinum neurotoxins (BoNT) and the ease of production, transport, and delivery make this an agent of extreme bioterrorism concern. Nonetheless, although there are major vaccine development initiatives ongoing, there currently is no approved Botulinum toxin vaccine available. Advances i ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Anionic Phospholipid-Selective PET/SPECT Agent for Infection Imaging

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Although a rapid and accurate diagnosis is crucial to the management of patients suspected of bacterial infection, the currently available radiopharmaceuticals are not capable of distinguishing between sterile inflammation and bacterial infections. Our goal is to develop an infection-specific PET/SPECT radiopharmaceutical for eventual use in clinical practice. ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Biased Agonism In GPCR Drug Discovery: Application To Somatostatin Agonists

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: NIGMS

    DESCRIPTION: Tracing neuronal connections with lipophilic carbocyanine dyes has revolutionized neuroanatomical tract tracing and is an essential feature to understand development of brain connections in both control and mutant mice in particular since multiple colors of dyes can be used. More recently, lipophilic dyes have also gained ground in labeling blood vessels by directly staining the endo ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  6. IGF::OT::IGF SBIR Topic 85 To support the development of target specific molecular imaging agents in combination with existing imaging modalities to detect high risk atherosclerotic plaque.

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: NHLBI

    Not Available

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Topic 368: Biotherapy of Brain Tumors by Radioiodinated SapC-DOPS Nanovesicles

    SBC: MOLECULAR TARGETING TECHNOLOGIES, INC.            Topic: NCI

    There is an urgent need for more effective drug delivery agents for treatment of brain tumors, which are among the most aggressive and intractable cancers. SapC-DOPS, a nanovesicle composed of saposin C (SapC) coupled to dioleoylphosphatidylserine (DOPS), has proven tumor targeting properties, which include crossing the blood-brain tumor barrier and binding the lipid tumor marker, extracellular ph ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. EBO-Scenario Generation

    SBC: SECURBORATION, INC.            Topic: N/A

    Securboration is pleased to propose an innovative approach to linking Effect Based Operation (EBO) Center Of Gravity analysis with simulation tools to determine the most effective Course Of Action (COA) to achieve the desired effects, entitled EBO-Scenario-Generation. EBO- Scenario-Generation concept is based on five years of research in to automated Scenario Generation capabilities. The ability ...

    SBIR Phase I 2002 Department of DefenseAir Force
  9. EBO-Scenario Generation

    SBC: SECURBORATION, INC.            Topic: N/A

    Securboration Inc. is pleased to propose an innovative approach to the automated creation of complete scenarios, or Scenario Generation (SGen), for mission planning simulation. This approach is a continuation of our Phase I effort, which successfullyvalidated our approach to scenario generation, and refined how scenario generation technology can be directly applied to problems facing the Effects ...

    SBIR Phase II 2003 Department of DefenseAir Force
  10. Information Uncertainty Portrayal

    SBC: SECURBORATION, INC.            Topic: N/A

    Securboration Inc., teaming with Dr. Eugene Santos of the University of Connecticut, is pleased to propose our innovative approach for visualizing and assessing uncertainty entitled, Uncertainty Prediction System (UPSYS). During the phase one effort weplan to demonstrate how the innovative UPSYS technology can be applied to supports visualization and assessment of event uncertainty within the con ...

    SBIR Phase I 2003 Department of DefenseAir Force
US Flag An Official Website of the United States Government